HBIO241115P6000
- 0.00
- 0.000.00%
Harvard Bioscience Newsroom
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
The Past Three Years for Harvard Bioscience (NASDAQ:HBIO) Investors Has Not Been Profitable
Sidoti Events, LLC's Virtual September Small-Cap Conference
Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference
Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Be 50% Below Their Intrinsic Value Estimate
Earnings Call Summary | Harvard Bioscience(HBIO.US) Q2 2024 Earnings Conference
Harvard Bioscience | 10-Q: Q2 2024 Earnings Report
Harvard Bioscience Non-GAAP EPS of $0.00 Misses by $0.05, Revenue of $23.1M Misses by $3.3M
Harvard Bioscience: Q2 Earnings Snapshot
Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q2 Revenue $23.1M, Vs. Street Est of $26.4M
Express News | Harvard Bioscience Inc - Reducing Its Full Year 2024 Revenue Outlook to Approximately $97 Mln to $102 Mln
Express News | Harvard Bioscience Q2 Revenue USD 23.1 Million
Express News | Harvard Bioscience Q2 Gross Margin 57.2%
Express News | Harvard Bioscience Q2 Adjusted Operating Income USD 800 Thousand
Express News | Harvard Bioscience Announces Second Quarter 2024 Financial Results
Institutional Investors May Adopt Severe Steps After Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Latest 13% Drop Adds to a Year Losses
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
Harvard Bioscience Insider Ups Holding During Year
Holley And 2 Other Stocks Under $5 Insiders Are Buying
Harvard Bioscience(HBIO.US) Officer Buys US$29,100 in Common Stock
$Harvard Bioscience(HBIO.US)$ Officer Green James W purchased 10,000 shares of common stock on Jun 13, 2024 at an average price of $2.91 for a total value of $29,100.Source: Announcement What is state